Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Chromium Update: Examining Recent Literature 1997-1998.

H. Preuß, R. Anderson
Published 1998 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Trivalent chromium is an essential nutrient required for sugar and fat metabolism. The majority of people eating typical Western diets consume less than the upper limit of the estimated safe and adequate daily dietary intake, which is set at 50-200 micrograms per day. Insufficient chromium intake is associated with signs and symptoms similar to those seen in diabetes and cardiovascular diseases. The efficacy of chromium in the general population relates to its prevention of deficiency or a reduction in the risk of chronic diseases. It is possible that doses above the estimated safe and adequate daily dietary intake are necessary for the treatment of certain chronic disease states. In a study performed in China, the use of 1000 micrograms of chromium per day (five times above the upper limit of the estimated safe and adequate daily dietary intake) was highly effective in relieving many of the symptomatic manifestations of type 2 diabetes mellitus, including a return of the HbA1C levels into the normal range. Most recent evidence strongly supports the conclusion that there is little fear of toxic reactions from chromium consumption. In addition to type 2 diabetes mellitus, chromium supplementation may be useful to direct overall weight decrements specifically towards fat loss with the retention of lean body mass and to ameliorate many manifestations of aging.
This paper references
10.1016/S0026-0495(97)90179-7
Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients--implications for the prevention of cardiovascular disease and type II diabetes mellitus.
S. Davies (1997)
10.1016/S0305-0491(97)00023-0
Effect of supplemental chromium on whole-body kinetics of glucose, lactate, and propionate in rams fed a high grain diet.
H. Sano (1997)
10.1016/S0306-9877(97)90251-6
Trivalent chromium and the diabetes prevention program.
L. Linday (1997)
10.1080/07315724.1998.10718732
The insulin system: influence of antioxidants.
H. Preuß (1998)
10.1093/GERONJ/47.6.B202
Dietary restriction alters characteristics of glucose fuel use.
E. Masoro (1992)
10.1080/07315724.1997.10718685
Lack of toxicity of chromium chloride and chromium picolinate in rats.
R. Anderson (1997)
10.1016/S0026-0495(98)90049-X
Dietary chromium decreases insulin resistance in rats fed a high-fat, mineral-imbalanced diet.
J. Striffler (1998)
10.2527/1997.7571956X
Effect of shipping and chromium supplementation on performance, immune response, and disease resistance of steers.
E. Kegley (1997)
10.1093/JN/128.2.180
Chromium picolinate modulates rat vascular smooth muscle cell intracellular calcium metabolism.
J. W. Moore (1998)
10.1080/07315724.1997.10718704
Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence.
H. Preuß (1997)
10.1096/fasebj.9.15.8529845
Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells 1
D. Stearns (1995)
10.1345/aph.17327
Chromium Picolinate Toxicity
J. Cerulli (1998)
10.1080/07315724.1997.10718705
Nutritional factors influencing the glucose/insulin system: chromium.
R. Anderson (1997)
10.1111/J.1753-4887.1997.TB01565.X
Confirmation: chromium levels in serum, hair, and sweat decline with age.
W. Mertz (1997)
10.1097/00005768-199708000-00003
Chromium and exercise training: effect on obese women.
K. E. Grant (1997)
10.2527/1997.753657X
Beneficial effects of chromium on glucose and lipid variables in control and somatotropin-treated pigs are associated with increased tissue chromium and altered tissue copper, iron, and zinc.
R. Anderson (1997)
10.1021/BI963154T
Chromium oligopeptide activates insulin receptor tyrosine kinase activity.
C. M. Davis (1997)
10.3168/JDS.S0022-0302(97)76107-1
Performance and glucose metabolism in calves fed a chromium-nicotinic acid complex or chromium chloride.
E. Kegley (1997)
10.2337/diab.46.11.1786
Elevated Intakes of Supplemental Chromium Improve Glucose and Insulin Variables in Individuals With Type 2 Diabetes
R. Anderson (1997)
10.1016/S0011-393X(96)80080-4
Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study
G. Kaats (1996)
10.1016/S0011-393X(98)85040-6
A randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: A replication and extension of a previous study
G. Kaats (1998)
10.1006/rtph.1997.1136
Chromium as an essential nutrient for humans.
R. Anderson (1997)
10.1093/AJCN/66.2.427
Vitamins and minerals: efficacy and safety.
J. Hathcock (1997)
10.7326/0003-4819-126-5-199703010-00019
Chronic Renal Failure after Ingestion of Over-the-Counter Chromium Picolinate
W. Wasser (1997)
10.1080/07315724.1998.10718729
Micronutrients as nutriceutical interventions in diabetes mellitus.
J. Cunningham (1998)
10.7326/0003-4819-127-8_Part_1-199710150-00028
Over-the-Counter Chromium and Renal Failure
W. Wasser (1997)
10.1016/S0946-672X(97)80045-4
Trace elements and chronic liver diseases.
C. Loguercio (1997)
10.1093/JN/128.1.73
Acute and chronic resistive exercise increase urinary chromium excretion in men as measured with an enriched chromium stable isotope.
M. Rubin (1998)



This paper is referenced by
10.1023/A:1020611925819
Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model
J. Vinson (2004)
10.2165/00024677-200403010-00005
The Role of Antioxidant Micronutrients in the Prevention of Diabetic Complications
D. Bonnefont‐Rousselot (2004)
10.1016/j.cvsm.2012.12.002
Oral hypoglycemics in cats with diabetes mellitus.
C. Palm (2013)
10.1007/s11010-009-0342-8
Long-term metabolic effects of different doses of niacin-bound chromium on Sprague-Dawley rats
N. Perricone (2009)
10.1007/s11010-007-9623-2
Cholesterol efflux and the effect of combined treatment with niacin and chromium on aorta of hyperlipidemic rat
Songul Suren Castillo (2007)
10.1016/S0300-483X(02)00378-5
Cytotoxicity and oxidative mechanisms of different forms of chromium.
D. Bagchi (2002)
10.1016/j.jinorgbio.2008.07.012
Comparing metabolic effects of six different commercial trivalent chromium compounds.
H. Preuß (2008)
Tribocorrosion properties of metallic materials and effects of metal release
M. S. Jellesen (2007)
10.1016/J.JINORGBIO.2007.03.015
Long-term safety evaluation of a novel oxygen-coordinated niacin-bound chromium (III) complex.
M. Shara (2007)
10.1016/J.JOMH.2010.01.002
An integrative medicine approach to managing nutrient depletions in the cardiometabolic patient
A. Heyman (2010)
10.1201/9781420082227-C15
Nutraceuticals and Weight Management
Gwendolyn W Pla (2009)
10.1016/j.jinorgbio.2009.03.008
Safety of an oxygen-coordinated niacin-bound chromium(III) complex (NBC): II. Developmental toxicity study in rats.
N. S. Deshmukh (2009)
10.1111/1539-6924.00343
Safety impacts of SUVs, vans, and pickup trucks in two-vehicle crashes.
E. L. Toy (2003)
10.1080/15376520600709746
Safety Assessment of a Novel Niacin-Bound Chromium-Based Energy Formulation
M. Shara (2006)
10.1201/9781420032208.CH19
Chromium: exposure, toxicity, and biomonitoring approaches
A. Zhitkovich (2002)
10.5539/gjhs.v6n3p90
Responses of Trace Elements to Aerobic Maximal Exercise in Elite Sportsmen
A. Otağ (2014)
10.1016/j.jinorgbio.2008.02.004
Blood pressure lowering effects of niacin-bound chromium(III) (NBC) in sucrose-fed rats: renin-angiotensin system.
N. Perricone (2008)
10.1046/j.1463-1326.2002.00180.x
Effects of a water‐soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice
V. Manohar (2002)
Micronutrient requirements in older women 1 – 3
R. Chernoff (2005)
10.1385/BTER:101:3:219
Beneficial effects of combined treatment with niacin and chromium on the liver of hyperlipemic rats
S. Bolkent (2007)
10.1016/S0946-672X(02)80003-7
Trace mineral status in post menopausal women: impact of hormonal replacement therapy.
I. Bureau (2002)
Analyse des données récentes sur le rôle du vin et de ses constituants dans la prévention des maladies cardiovasculaires
D. Marigo (2002)
10.1007/s12011-017-0985-3
The Effects of Supplementary Cr3 (Chromium(III) Propionate Complex) on the Mineral Status in Healthy Female Rats
H. Staniek (2017)
10.1016/B978-044453071-4/50010-2
Benefits of chromium(III) complexes in animal and human health
Shirley Zafra-Stone (2007)
Zinco, crómio e diabetes mellitus
Inês Margarida Araújo Soares Costa Tomada Marques (2000)
10.1016/J.JNUTBIO.2006.11.008
HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults.
J. L. Zenk (2007)
10.3746/pnf.2012.17.4.299
The Supplementation of Yam Powder Products Can Give the Nutritional Benefits of the Antioxidant Mineral (Cu, Zn, Mn, Fe and Se) Intakes
M. Shin (2012)
Let ’ s Juice ! What the Glycemic Index Really Says About Carrot Juice and Blood Glucose
M. Donaldson (2001)
10.1093/AJCN/81.5.1240
Micronutrient requirements in older women.
R. Chernoff (2005)
10.1201/9781420005479.CH26
Chromium (III) in Promoting Weight Loss and Lean Body Mass
D. Bagchi (2007)
10.1016/J.JINORGBIO.2005.07.017
Safety and toxicological evaluation of a novel niacin-bound chromium (III) complex.
M. Shara (2005)
10.1016/S0749-0739(02)00006-8
The equine metabolic syndrome peripheral Cushing's syndrome.
P. Johnson (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar